MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE
Clinical trials for MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE explained in plain language.
Never miss a new study
Get alerted when new MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE trials appear
Sign up with your email to follow new studies for MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm Crohn's flares and heal the gut
Disease control Recruiting nowThis large, late-stage study is testing whether a new drug called Afimkibart can help people with moderate-to-severe Crohn's disease. It will compare the drug against a placebo in 425 participants to see if it reduces symptoms and improves gut healing. The main goals are to see i…
Matched conditions: MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major Crohn's trial aims to heal gut, stop symptoms
Disease control Recruiting nowThis large, late-stage study is testing whether a new drug called Afimkibart can help people with moderate-to-severe Crohn's disease. It aims to reduce gut inflammation, relieve symptoms like diarrhea and pain, and help patients achieve remission. The study will involve about 600…
Matched conditions: MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC